Search results for "DISEASE PROGRESSION"

showing 10 items of 835 documents

Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients

2014

High levels of cell free DNA (cfDNA) in human blood plasma have been described in patients with autoimmune diseases. The aim of this study was to determine the levels of cfDNA in systemic lupus erythematosus (SLE) patients and to assess fluctuations of cfDNA concentrations compared to the course of disease progression under standard treatment. Therefore, nuclear cfDNA concentrations in plasma were measured in 59 SLE patients and 59 healthy controls. Follow-up blood plasma was collected from 27 of the 59 SLE patients. Patients were characterised by clinical parameters (antinuclear antibodies (ANA), anti-dsDNA-antibodies, C3, C4, and CRP), SLE disease activity index (SLEDAI) and medical thera…

AdultMalemedicine.medical_specialtyAnti-nuclear antibodyImmunologyBiologyGastroenterologyDisease courseimmune system diseasesInternal medicineBlood plasmamedicineHumansLupus Erythematosus SystemicIn patientskin and connective tissue diseasesCell-Free SystemStandard treatmentDisease progressionMedical evaluationDNACell-free fetal DNAImmunologyDisease ProgressionFemaleBiomarkersCellular Immunology
researchProduct

Central motor conduction time by magnetic stimulation of the cortex and peripheral nerve conduction follow-up studies in Friedreich's ataxia.

1998

A follow-up clinical study, peripheral motor and sensory nerve conduction velocities and central motor conduction by magnetic stimulation of the cortex were performed in 13 patients with classical Friedreich's ataxia (FA) phenotype, for a period of 9-12 years. Clinical worsening was unrelated to peripheral nerve abnormalities. The amplitude of the nerve action potentials and delayed conduction velocity remained unchanged for several years. Central motor conduction times were abnormal in all patients. Clinical conditions worsened significantly between successive examinations with significant increments in threshold and significant decrement of the amplitude of motor evoked potentials. The re…

AdultMalemedicine.medical_specialtyAtaxiaAdolescentNeural ConductionMotor nerveElectromyographyNerve conduction velocityMagneticsSural NerveTrinucleotide RepeatsInternal medicineCerebellumPhysical StimulationReaction TimeMedicineHumansNeurons AfferentPeripheral NervesChildMuscle SkeletalNeural ConductionMotor Neuronsmedicine.diagnostic_testbusiness.industryElectromyographyGeneral NeurosciencePyramidal CellsMotor CortexMiddle AgedMedian Nervemedicine.anatomical_structureFriedreich AtaxiaPeripheral nervous systemCardiologyDisease ProgressionFemaleNeurology (clinical)medicine.symptomH-reflexbusinessNeuroscienceSensory nerveFollow-Up StudiesElectroencephalography and clinical neurophysiology
researchProduct

Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.

2020

Aim We aimed to identify whether lifetime cocaine use is a risk factor for conversion from major depressive disorder (MDD) to bipolar disorder (BD) in an outpatient sample of adults. Methods This prospective cohort study included 585 subjects aged 18 to 60 years who had been diagnosed with MDD as assessed by the Mini International Neuropsychiatric Interview (MINI-Plus) at baseline (2012-2015). Subjects were reassessed a mean of 3 years later (2017-2018) for potential conversion to BD as assessed by the MINI-Plus. Lifetime cocaine use was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test. Results In the second wave, we had 117 (20%) losses, and 468 patients were r…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentPoison control03 medical and health sciencesCocaine-Related DisordersYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansBipolar disorderProspective StudiesRisk factorProspective cohort studyMini-international neuropsychiatric interviewDepressive Disorder Majorbusiness.industryGeneral NeuroscienceGeneral MedicineMiddle Agedmedicine.diseaseConfidence interval030227 psychiatryPsychiatry and Mental healthNeurologyCohortDisease ProgressionMajor depressive disorderFemaleNeurology (clinical)business030217 neurology & neurosurgeryPsychiatry and clinical neurosciencesReferences
researchProduct

Long-Term Outcome of Cognitive Impairment in Bipolar Disorder

2011

OBJECTIVE: To evaluate the longitudinal course and outcome of cognitive deficits and their clinical correlates in bipolar disorder. METHOD: One hundred thirteen participants (68 patients and 45 healthy controls) were assessed by the means of a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions at baseline: 68 euthymic outpatients with a DSM-IV diagnosis of bipolar disorder (53 bipolar I and 15 bipolar II) were enrolled at the Bipolar Disorder Unit of the Hospital Clinic of Barcelona. Forty-five patients completed the follow-up. The assessments started in February 1999 and finished in July 2010. The primary outcome of the study was the c…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsPsychometricsNeuropsychological TestsExecutive FunctionmedicineHumansBipolar disorderPsychomotor learningWechsler ScalesNeuropsychologyWechsler Adult Intelligence ScaleCognitionMiddle Agedmedicine.diseaseExecutive functionsPsychiatry and Mental healthDisease ProgressionPhysical therapyFemaleVerbal memoryCognition DisordersPsychologyFollow-Up StudiesClinical psychologyThe Journal of Clinical Psychiatry
researchProduct

Risk factors for locally advanced cancer associated with ulcerative colitis: Results of a retrospective multicentric study in the era of biologics

2020

Abstract Background Patients affected by ulcerative colitis (UC) are more likely to develop colorectal cancer, and are often diagnosed with lymph node involvement (N+) at surgery. Aim To identify the risk factors for N+ cancer in UC patients. Methods Patients undergoing surgery from 2001 to 2018 in six European tertiary centres were included. N+ patients were compared to the control group (N−) for clinical variables. The evaluation of risk factors for N+ was assessed using univariate and multivariable logistic regression analyses. Results A total of 130 patients were included. Median duration of disease was 21 years (1–52). Forty patients (30.8%) were N+ at surgery. Eighteen (13.8%) develop…

AdultMalemedicine.medical_specialtyCancer Lymph nodes Ulcerative colitisTime FactorsAdolescentColorectal cancerDiseaseLogistic regression03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansChildLymph nodeColectomyAgedRetrospective StudiesCancerHepatologybusiness.industryLocally Advanced CancerGastroenterologyCancerOdds ratioColonoscopyMiddle Agedmedicine.diseaseUlcerative colitismedicine.anatomical_structureLogistic ModelsItalyUlcerative colitis030220 oncology & carcinogenesisMultivariate AnalysisDisease Progression030211 gastroenterology & hepatologyColitis UlcerativeFemaleLymph nodeLymph NodesbusinessColorectal Neoplasms
researchProduct

Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery.

2010

Aiming at avoidance of futile surgery, we have tested whether radiofrequency ablation (RFA) may be used as first-line treatment in patients with colorectal metastases (CRLM) occurring within the first year after colorectal surgery.Surgical resection is the standard treatment in patients with CRLM. Major retrospective analyses have identified the interval between colorectal surgery and the occurrence of CRLM to be of prognostic importance. So far, it is unknown whether survival of the respective patients is hampered if RFA is used as first-line treatment.According to a clinical pathway, we have treated patients with CRLM detected within the first year after colorectal surgery preferentially …

AdultMalemedicine.medical_specialtyColorectal cancerRadiofrequency ablationmedicine.medical_treatmentCatheter ablationlaw.inventionlawmedicineHepatectomyHumansIn patientSurvival analysisAgedRetrospective Studiesbusiness.industryLiver NeoplasmsCancerRetrospective cohort studyLength of StayMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryCatheter AblationDisease ProgressionSurgeryFemaleHepatectomyNeoplasm Recurrence LocalbusinessColorectal NeoplasmsAnnals of surgery
researchProduct

A discrete-choice experiment to assess patients’ preferences for osteoarthritis treatment: An ESCEO working group

2020

Objective: To evaluate the preferences of patients with osteoarthritis for treatment.Methods: A discrete-choice experiment was conducted among adult OA patients who were presented with 12 choice sets of two treatment options and asked in each to select the treatment they would prefer. Based on literature reviews, expert consultation, patient survey and expert meeting, treatment options were characterized by seven attributes: improvement in pain, improvement in walking, ability to manage domestic activities, ability to manage social activities, improvement in overall energy and well-being, risk of moderate/severe side effects and impact on disease progression. Random parameters logit model w…

AdultMalemedicine.medical_specialtyDiscrete choice experimentOsteoarthritisOutcomes03 medical and health sciences0302 clinical medicinePHYSICIANSRheumatologySurveys and QuestionnairesOsteoarthritisMedicineHumans030212 general & internal medicineAgedOutcome030203 arthritis & rheumatologyddc:616HIPbusiness.industryDisease progressionDiscrete-choice experimentTreatment optionsPatient PreferencePatient preferencesmedicine.diseaseLatent class modelPreferenceEuropeInstitutional repositoryAnesthesiology and Pain MedicineLogistic ModelsPhysical therapyPatient surveyFemaleKNEEOsteoarthritiHEALTHbusiness
researchProduct

Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study

2007

In patients with relapsing-remitting multiple sclerosis (MS), IVIG was shown to reduce the relapse rate and progression of disability. In patients with chronic progressive MS, a beneficial effect of IVIG was not documented in placebo controlled studies. This trial investigated the influence of IVIG in primary (PPMS) and secondary (SPMS) chronic progressive MS. Two-hundred and thirty-one patients stratified for PPMS ( n = 34) and SPMS ( n = 197) were randomly assigned to IVIG 0.4 g/kg per month or to placebo for 24 months. Primary endpoints were 1) the time to sustained progression of disease identified as worsening of the expanded disability status scale (EDSS) sustained for 3 months, and …

AdultMalemedicine.medical_specialtyDiseasePlaceboPlacebosCentral nervous system diseaseDisability EvaluationDegenerative diseaseQuality of lifeRecurrencehemic and lymphatic diseasesInternal medicinemedicineHumansImmunologic FactorsProspective StudiesDepression (differential diagnoses)AgedExpanded Disability Status Scalebusiness.industryMultiple sclerosisImmunoglobulins IntravenousMiddle AgedMultiple Sclerosis Chronic Progressivemedicine.diseaseSurgeryTreatment OutcomeNeurologyDisease ProgressionFemaleNeurology (clinical)businessMultiple Sclerosis Journal
researchProduct

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

2011

The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri (GC) and to define clinical, imaging, and molecular factors influencing outcome.Thirty-five patients with previously untreated GC were treated with up to six 56-day courses of 110mg/m(2) lomustine on day 1 and 60mg/m(2) procarbazine on days 8 to 21. The primary endpoint was the rate of patients without therapy failure (defined as progressive disease, death from any cause, or termination of PC therapy before the end of course 4) at 8 months after the beginning of PC chemotherapy.The failure-free survival rate at 8 months was 50.3…

AdultMalemedicine.medical_specialtyEndpoint DeterminationGliomatosis cerebriAntineoplastic AgentsGene mutationProcarbazineGastroenterologyDisease-Free SurvivalLomustineInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansProspective StudiesKarnofsky Performance StatusSurvival rateDNA Modification MethylasesAgedbusiness.industryTumor Suppressor ProteinsHazard ratioBrainLomustineMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyMagnetic Resonance ImagingNeoplasms NeuroepithelialSurvival AnalysisSurgeryDNA Repair EnzymesTreatment OutcomeNeurologyProcarbazineSample SizeDisease ProgressionFemaleNeurology (clinical)businessProgressive diseasemedicine.drugAnnals of neurology
researchProduct

Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and ade…

2006

AIM: C-reactive protein (CRP) is an acute-phase reactant and a known indicator of the malignant potential of the tumour. The aim of this study was to investigate the significance of preoperative CRP as a parameter of the perioperative course and long-term prognosis in patients with squamous cell carcinoma and adenocarcinoma of the oesophagus. METHODS: Serum CRP was determined preoperatively in 291 of 371 patients undergoing oesophagectomy for cancer from December 1989 to March 2004. Median patient age was 59 (28-79) year, 82.5% of patients were males. Squamous cell carcinoma was diagnosed in 151 (51.9%) and adenocarcinoma in 122 patients. Transhiatal oesophagectomy was done in 151 (51.9%) p…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsAdenocarcinomaSeverity of Illness IndexGastroenterologyPerioperative CarePredictive Value of TestsInternal medicineBiomarkers TumorOdds RatiomedicineHumansSurvival rateAgedNeoplasm Stagingbiologybusiness.industryC-reactive proteinHazard ratioGastroenterologyCancerGeneral MedicinePerioperativeOdds ratioMiddle AgedPrognosismedicine.diseaseSurgeryC-Reactive ProteinPredictive value of testsMultivariate AnalysisCarcinoma Squamous CellDisease Progressionbiology.proteinAdenocarcinomaFemalebusinessRapid CommunicationFollow-Up StudiesWorld Journal of Gastroenterology
researchProduct